AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
• Scienture Holdings reports Q3 revenue of $590K, up from $65K in 2024. • Gross profit increases to $575K from $4K in 2024. • Launched sales of Arbli, an FDA-approved hypertension treatment. • Net revenue and gross profit show significant growth compared to Q3 2024.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet